Please use this identifier to cite or link to this item: https://doi.org/10.1046/j.0269-4727.2003.00515.x
Title: Stability of extemporaneously prepared saquinavir formulations
Authors: Tan, L.K.
Thenmozhiyal, J.C. 
Ho, P.C. 
Keywords: Extemporaneously prepared formulation
Saquinavir
Stability
Issue Date: Dec-2003
Citation: Tan, L.K., Thenmozhiyal, J.C., Ho, P.C. (2003-12). Stability of extemporaneously prepared saquinavir formulations. Journal of Clinical Pharmacy and Therapeutics 28 (6) : 457-463. ScholarBank@NUS Repository. https://doi.org/10.1046/j.0269-4727.2003.00515.x
Abstract: Aims: The effects of pH and excipients on the stability of saquinavir in extemporaneously prepared suspensions were assessed. The stability of a developed extemporaneously prepared saquinavir suspension was then determined at 5 and 25°C over 30 days. Method: Extemporaneous saquinavir 2 mg/mL formulations were prepared from soft gelatin capsule (Fortovase). Four batches of the formulations were buffered at pHs 2, 4, 5 and 7, whereas the other five batches were prepared in Milli-Q water, 0.5% (w/v) citric acid, 0.1% (w/v) sodium ascorbate, 10% (v/v) syrup and in vehicle containing both 0.5% (w/v) citric acid and 0.1% (w/v) sodium ascorbate. The stability of these formulations was tested at 25°C. A final formulation of saquinavir suspension (60 mg/mL) containing both 10% (v/v) syrup and 0.5% (w/v) citric acid was developed and tested for stability at 5 and 25°C for up to 30 days using a stability-indicating high-performance liquid chromatographic method. Results: Saquinavir was most stable at pH 2-4. Formulations containing sodium ascorbate, citric acid and syrup or both citric acid and sodium ascorbate were significantly more stable than the control formulation (saquinavir 2 mg/mL in Milli-Q water). Conclusion: The pH for optimal stability of saquinavir was around 2-4. Besides pH adjustment, saquinavir could also be stabilized by adding anti-oxidants. The saquinavir 60 mg/mL formulation prepared with about a pH of about 4 was stable at both 5 and 25°C for at least 30 days.
Source Title: Journal of Clinical Pharmacy and Therapeutics
URI: http://scholarbank.nus.edu.sg/handle/10635/106359
ISSN: 02694727
DOI: 10.1046/j.0269-4727.2003.00515.x
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

3
checked on Nov 14, 2018

WEB OF SCIENCETM
Citations

2
checked on Nov 6, 2018

Page view(s)

41
checked on Sep 21, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.